Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
“Trials of lenalidomide (revlimid) in a less intensive approach has shown promise in delaying disease progression and should be investigated further in clinical trials.” You’ve been diagnosedContinue reading
“The multivariable regression analysis was performed to obtain the significant prognosis that was used to establish the nomogram for 3-, 5-, and 10-year OS.” I was diagnosed with a single boneContinue reading
“New studies (pre-habilitation) suggest that a multimodal approach that incorporates both physical and psychological prehabilitation interventions may be more effective than a unimodal approach thatContinue reading
Should we treat patients with myeloma with multidrug, multitransplant combinations with the goal of potentially curing a subset of patients, recognizing that the risk of adverse events and effect on qualityContinue reading
“Lenalidomide (Revlimid) induced a 72% reduction in the risk of progression to symptomatic disease in patients with smoldering multiple myeloma at 3 years” The challenge with pre-myeloma, MonoclonalContinue reading
“Patients with monoclonal gammopathy of undetermined significance (MGUS) have twice the risk of developing multiple myeloma (MM) if they have non-antibody (Ab)-mediated rheumatic diseases (RDs)…” RheumaticContinue reading
“Bortezomib with dexamethasone as first-line treatment for AL amyloidosis with renal involvement…in multiple myeloma or MGUS patients?” You’ve been diagnosed with multiple myelomaContinue reading